查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球製藥膜過濾市場（~2029）：依產品（過濾系統）、技術、應用、類型和業務規模
市場調查報告書
商品編碼
1451940

全球製藥膜過濾市場（~2029）：依產品（過濾系統）、技術、應用、類型和業務規模

Pharmaceutical Membrane Filtration Market by Product (Filters, Systems), Technique, Application, Type, Scale of Operation - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 477 Pages | 訂單完成後即時交付

價格
簡介目錄

製藥膜過濾市場規模預計將從 2024 年的 106 億美元成長到 2029 年的 196 億美元，預測期內複合年成長率為 13.1%。

該市場的成長是由於最終用戶行業對純度的要求不斷提高。在生命科學產業，超純水對於基因組學、蛋白質組學、免疫學、藥理學、細胞和組織培養以及藥物發現至關重要。生命科學研究對 I 型超純研究級水的需求不斷成長，使得實驗室純水供應成為實驗室產業最重要、成長最快的市場之一。預計這一趨勢將在未來幾年推動製藥膜過濾市場的成長。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（美元）
部分 產品/技術/類型/應用/業務規模
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

按類型分類，無菌過濾領域將在 2023 年佔據最大佔有率

無菌過濾是去除微生物的過程，在確保最終產品的無菌方面發揮重要作用。無菌過濾器廣泛用於液體藥品的中間和過濾。根據監管機構的說法，無菌級過濾器在製藥最終產品最終產品加工中是必要的且至關重要。此外，無菌過濾器比非無菌過濾器具有許多優勢，使其成為製藥和生物製藥行業上游和下游製程的首選。

按地區分類，預計美國在預測期內將繼續主導市場。

2023年，美國主導北美製藥膜過濾市場。美國是全球最大的生物製藥市場，也是生物製藥研究和投資的領導者。此外，美國還擁有一些世界領先的學術研究機構，包括哈佛大學、史丹佛大學和麻省理工學院（MIT）。這些研究機構在藥物發現、基因組學和生物技術等生命科學領域進行前沿研究，需要使用薄膜過濾產品。過濾膜技術的進步和專利數量的增加也支持過濾在製藥和生物技術行業的採用。

該報告調查了全球製藥膜過濾市場，並提供了市場概況、市場影響因素和市場機會分析、技術和專利趨勢、法律制度、案例研究、市場規模趨勢和預測以及各種分類。,編制了詳細的區域分析、競爭形勢、主要企業概況等

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 技術分析
  • 供應鏈分析
  • 價值鏈分析
  • 生態系分析
  • 影響客戶業務的趨勢/干擾
  • 價格分析
  • 監管狀況
  • 專利分析
  • 投資/融資活動
  • 重大會議及活動
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 案例研究分析

第6章製藥膜過濾市場：依產品

  • 薄膜過濾器
    • 聚醚碸膜過濾器
    • Polyvinylidene薄膜過濾器
    • 尼龍薄膜過濾器
    • 聚四氟乙烯濾膜
    • 混合纖維素酯和醋酸纖維素膜過濾器
    • 聚碳酸酯徑跡蝕刻膜過濾器
    • 其他
  • 系統
    • 免洗系統
    • 可重複使用的系統
  • 其他產品
    • 薄膜過濾組件
    • 配件

第7章製藥膜過濾市場：依技術分類

  • 微過濾
  • 超過濾
  • 奈米過濾
  • 其他

第8章製藥膜過濾市場：依應用分類

  • 最終產品加工
    • 活性藥物成分 (API)過濾
    • 蛋白質精製
    • 疫苗和抗體加工
    • 配方和填充解決方案
    • 病毒清除
  • 原料過濾
    • 介質和緩衝液的過濾
    • 預過濾
    • 微生物附著量測試
  • 細胞分離
  • 淨水
  • 空氣淨化

第9章製藥膜過濾市場：依類型

  • 無菌過濾
  • 非無菌過濾

第10章製藥膜過濾市場：依業務規模分類

  • 製造規模
  • 中試規模
  • 研發規模

第11章製藥膜過濾市場：按地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第12章競爭形勢

  • 主要企業的招募策略
  • 收益佔有率分析
  • 市場佔有率分析
  • 企業評價矩陣：主要企業
  • 主要企業的競爭基準化分析
  • 公司評估矩陣：Start-Ups/中小企業
  • 新興企業/中小企業的競爭基準化分析
  • 製藥膜過濾供應商評估和財務指標
  • 品牌/產品比較分析
  • 競爭場景

第13章 公司簡介

  • 主要企業
    • MERCK KGAA
    • DANAHER CORPORATION
    • SARTORIUS AG
    • THERMO FISHER SCIENTIFIC INC.
    • 3M COMPANY
    • PARKER HANNIFIN CORPORATION
    • REPLIGEN CORPORATION
    • ASAHI KASEI CORPORATION
    • EATON CORPORATION PLC
    • GEA GROUP
    • CORNING INCORPORATED
    • ALFA LAVAL CORPORATE AB
    • DONALDSON COMPANY, INC.
    • SAINT-GOBAIN
    • MANN+HUMMEL INTERNATIONAL GMBH & CO. KG
    • MEISSNER FILTRATION PRODUCTS, INC.
    • COLE-PARMER INSTRUMENT COMPANY, LLC
    • APPLEXION
    • CANTEL MEDICAL CORP.
    • WL GORE & ASSOCIATES, INC.
  • 其他公司
    • MEMBRANE SOLUTIONS
    • AMAZON FILTERS LTD.
    • TOYO ROSHI KAISHA, LTD.
    • PORVAIR PLC
    • STERLITECH CORPORATION
    • SYNDER FILTRATION, INC.
    • GRAVER TECHNOLOGIES, LLC
    • KOCH MEMBRANE SYSTEMS, INC.
    • NUPORE FILTRATION SYSTEMS
    • COBETTER FILTRATION EQUIPMENT CO., LTD.

第14章附錄

簡介目錄
Product Code: BT 2255

The global pharmaceutical membrane filtration market is projected to reach USD 19.6 billion by 2029 from USD 10.6 billion in 2024, at a CAGR of 13.1% during the forecast period of 2024 to 2029. The growth of this market can be attributed to increasing purity requirements in end-use industries. In the life sciences industry, ultrapure water is essential for genomics, proteomics, immunology, pharmacology, cell and tissue culture, and drug discovery. Due to the increasing demand for Type I, ultrapure, or research-grade water in life science research, pure lab water supply has become one of the most important and fastest-growing markets in the laboratory industry. This trend is expected to drive the growth of the pharmaceutical membrane filtration market in the coming years.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct, Technique, Type, Application, And Scale Of Operation
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The sterile filtration segment accounted for the largest share by type in 2023."

In 2023, the sterile filtration segment accounted for the largest share by type in the global pharmaceutical membrane filtration market. Sterile filtration is the process of microbial removal and plays an important role in assuring final product sterility. Sterile filters are widely used for the intermediate and final filtration of liquid drug products. According to regulatory authorities, sterile-grade filters are required for the final product processing of drugs and are of utmost importance during final product processing. Moreover, there are various advantages of sterile filters over non-sterile filters, which make them the preferred choice for upstream and downstream processing in the pharmaceutical and biopharmaceutical industries.

"The US has continued to dominate the pharmaceutical membrane filtration market during the forecast period of 2024-2029."

The US dominated the pharmaceutical membrane filtration market in North America in 2023. The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Additionally, the US is home to some of the world's leading academic research institutes, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutes conduct cutting-edge research in life sciences, including drug discovery, genomics, and biotechnology, which require the use of membrane filtration products. Technological advancements in filtration membranes and the increasing number of patents are also driving the adoption of filtration in the pharmaceutical and biotechnology industries.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Thermo Fisher Scientific Inc. (US)

Merck KGaA (Germany)

Danaher Corporation (US)

Sartorius AG (Germany)

Thermo Fisher Scientific, Inc. (US)

3M Company (US)

Parker Hannifin Corporation (US)

Repligen Corporation (US)

Asahi Kasei Corporation (Japan)

Eaton Corporation plc (Ireland)

GEA Group (Germany)

Corning Incorporated (US)

Alfa Laval Corporate AB (Sweden)

Donaldson Company, Inc. (US)

Saint-Gobain (France)

MANN+HUMMEL International GmbH & Co. KG (Germany)

Meissner Filtration Products, Inc. (US)

Cole-Parmer Instrument Company, LLC (US)

Applexion (France)

Cantel Medical Corp. (US)

W. L. Gore & Associates Inc. (US)

Membrane Solutions (US)

Amazon Filters Ltd. (UK)

Toyo Roshi Kaisha, Ltd. (Japan)

Porvair plc (UK)

Sterlitech Corporation (US)

Synder Filtration, Inc. (US)

Graver Technologies, LLC (US)

Koch Membrane Systems, Inc. (US)

Nupore Filtration Systems (India)

Cobetter Filtration Equipment Co., Ltd. (China).

Research Coverage:

This research report categorizes the pharmaceutical membrane filtration market by product (membrane filters, systems, and other products), by technique (microfiltration, ultrafiltration, nanofiltration, and other techniques), by application (final product processing, raw material filtration, cell separation, water purification, and air purification), by type (sterile filtration and non-sterile filtration), by scale of operation (manufacturing scale operation, pilot scale operation, and R&D scale operation) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical membrane filtration market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the pharmaceutical membrane filtration market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical membrane filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (increasing adoption of single-use technologies, stringent regulatory requirements, rising R&D spending in pharmaceutical and biotechnology industries, and increasing purity requirements in end-use industries), restraints (membrane fouling issues and high capital investment requirements to limit entry of smaller players), opportunities (growing opportunities in emerging economies, advances in nanofiltration technology), and Challenges (increased cost and reduced speed & yield of filters) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products of the pharmaceutical membrane filtration market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical membrane filtration market
  • Competitive Assessment: Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), 3M Company (US), Parker Hannifin Corporation (US), Repligen Corporation (US), Asahi Kasei Corporation (Japan), Eaton Corporation plc (Ireland), GEA Group (Germany), Corning Incorporated (US), Alfa Laval Corporate AB (Sweden), Donaldson Company, Inc. (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY
  • 1.6 STAKEHOLDERS
  • 1.7 LIMITATIONS
  • 1.8 SUMMARY OF CHANGES
  • 1.9 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
    • FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SARTORIUS AG (2023)
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    • 2.2.3 TOP-DOWN APPROACH
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 GROWTH FORECAST
    • FIGURE 8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: CAGR PROJECTIONS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 MARKET FORECAST
    • TABLE 1 FACTOR ANALYSIS
  • 2.7 RISK ANALYSIS
  • 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL MEMBRANE FILTRATION MARKET

4 PREMIUM INSIGHTS

  • 4.1 PHARMACEUTICAL MEMBRANE FILTRATION MARKET OVERVIEW
    • FIGURE 16 RISING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT AND COUNTRY (2023)
    • FIGURE 17 MEMBRANE FILTERS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL MEMBRANE FILTRATION MARKET IN 2023
  • 4.3 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY APPLICATION, 2024 VS. 2029
    • FIGURE 18 FINAL PRODUCT PROCESSING SEGMENT TO DOMINATE MARKET IN 2029
  • 4.4 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY TECHNIQUE, 2023
    • FIGURE 19 MICROFILTRATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.5 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing adoption of single-use technologies
      • 5.2.1.2 Stringent regulatory requirements
      • 5.2.1.3 Rising R&D spending in pharmaceutical and biotechnology industries
    • FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014-2028 (USD BILLION)
      • 5.2.1.4 Increasing purity requirements in end-use industries
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Membrane fouling issues
      • 5.2.2.2 High capital investment requirements to limit entry of smaller players
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
      • 5.2.3.2 Advances in nanofiltration technology
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increased cost and reduced speed & yield of filters
  • 5.3 TECHNOLOGY ANALYSIS
    • TABLE 3 TECHNOLOGY ANALYSIS
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 23 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: SUPPLY CHAIN ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 24 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 25 PHARMACEUTICAL MEMBRANE FILTRATION MARKET ECOSYSTEM
    • 5.6.1 PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS
    • TABLE 4 PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS
    • 5.6.2 PHARMACEUTICAL MEMBRANE FILTRATION VENDORS
    • TABLE 5 PHARMACEUTICAL MEMBRANE FILTRATION VENDORS
    • 5.6.3 PHARMACEUTICAL MEMBRANE FILTRATION END USERS
    • TABLE 6 PHARMACEUTICAL MEMBRANE FILTRATION END USERS
    • 5.6.4 PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES
    • TABLE 7 PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 26 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: TRENDS/DISRUPTIONS IMPACTING CLIENT'S BUSINESS
  • 5.8 PRICING ANALYSIS
    • TABLE 8 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
    • 5.8.1 AVERAGE SELLING PRICE RANGE, BY REGION, 2023
    • TABLE 9 AVERAGE SELLING PRICE, BY REGION, 2023
  • 5.9 REGULATORY LANDSCAPE
    • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.9.2 REGULATORY SCENARIO IN DIFFERENT COUNTRIES
  • 5.10 PATENT ANALYSIS
    • 5.10.1 METHODOLOGY
    • 5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2013-2023
    • TABLE 15 PATENTS FILED, 2013-2023
    • 5.10.3 INNOVATION AND PATENT APPLICATIONS
    • FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014-2023
    • 5.10.4 TOP APPLICANTS
    • FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2023
    • TABLE 16 TOP 20 PATENT OWNERS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2014-2023
    • TABLE 17 PATENTS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2023
  • 5.11 INVESTMENT/FUNDING ACTIVITIES
  • 5.12 KEY CONFERENCES AND EVENTS, 2024
    • TABLE 18 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 19 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF BUYERS
    • 5.13.4 BARGAINING POWER OF SUPPLIERS
    • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS
    • 5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS AMONG END USERS
    • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
    • TABLE 20 BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION, BY END USER
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 CASE STUDY 1: PELLICON 2 CASSETTE PROCESSING OF THERAPEUTIC PROTEINS
    • 5.15.2 CASE STUDY 2: FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID
    • 5.15.3 CASE STUDY 3: 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS
    • 5.15.4 CASE STUDY 4: DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS
    • 5.15.5 CASE STUDY 5: USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS

6 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 21 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • 6.2 MEMBRANE FILTERS
    • TABLE 22 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 23 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 24 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 25 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 27 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 28 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 29 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.1 POLYETHERSULFONE MEMBRANE FILTERS
      • 6.2.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth
    • TABLE 30 POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 31 NORTH AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 32 EUROPE: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 33 ASIA PACIFIC: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 34 LATIN AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 35 MIDDLE EAST: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 36 GCC COUNTRIES: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS
      • 6.2.2.1 Non-toxic, highly pure, and biologically safe-advantages supporting market growth
    • TABLE 37 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 38 NORTH AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 39 EUROPE: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 41 LATIN AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 42 MIDDLE EAST: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 43 GCC COUNTRIES: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.3 NYLON MEMBRANE FILTERS
      • 6.2.3.1 Increased endotoxin adsorption capacity to drive growth
    • TABLE 44 NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 45 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 46 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 48 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 49 MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 50 GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS
      • 6.2.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ
    • TABLE 51 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 52 NORTH AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 53 EUROPE: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 55 LATIN AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 56 MIDDLE EAST: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 57 GCC COUNTRIES: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.5 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS
      • 6.2.5.1 Provide optically compatible surface for greater adsorption of products
    • TABLE 58 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 59 NORTH AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 60 EUROPE: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 62 LATIN AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 63 MIDDLE EAST: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 64 GCC COUNTRIES: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.6 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS
      • 6.2.6.1 Widely used in cell biology and analytical testing applications
    • TABLE 65 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 66 NORTH AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 67 EUROPE: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 69 LATIN AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 70 MIDDLE EAST: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 71 GCC COUNTRIES: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.7 OTHER MEMBRANE FILTERS
    • TABLE 72 OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 73 NORTH AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 74 EUROPE: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 76 LATIN AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 77 MIDDLE EAST: OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 78 GCC COUNTRIES: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3 SYSTEMS
    • TABLE 79 PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 80 PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 81 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 82 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 84 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 85 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 86 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1 SINGLE-USE SYSTEMS
      • 6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption
    • TABLE 87 SINGLE-USE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 88 NORTH AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 89 EUROPE: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 91 LATIN AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 92 MIDDLE EAST: SINGLE-USE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 93 GCC COUNTRIES: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.2 REUSABLE SYSTEMS
      • 6.3.2.1 Widely used for large-scale manufacturing
    • TABLE 94 REUSABLE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 95 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 96 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 97 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 98 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 99 MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 100 GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4 OTHER PRODUCTS
    • TABLE 101 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 102 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 103 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 104 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 106 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 107 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 108 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.4.1 MEMBRANE FILTRATION ASSEMBLIES
      • 6.4.1.1 Leading players provide pre-assembled filtration assemblies
    • TABLE 109 MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 110 NORTH AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 111 EUROPE: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 113 LATIN AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 114 MIDDLE EAST: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 115 GCC COUNTRIES: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.4.2 ACCESSORIES
      • 6.4.2.1 Increasing adoption of pharmaceutical membrane filtration products to support growth
    • TABLE 116 PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 117 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 118 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 120 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 121 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 122 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE

  • 7.1 INTRODUCTION
    • TABLE 123 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
  • 7.2 MICROFILTRATION
    • 7.2.1 AVAILABILITY OF INNOVATIVE AND COST-EFFECTIVE MICROFILTRATION MEMBRANES TO SUPPORT MARKET GROWTH
    • TABLE 124 PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 125 NORTH AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 126 EUROPE: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 128 LATIN AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 129 MIDDLE EAST: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 130 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3 ULTRAFILTRATION
    • 7.3.1 LEAST COSTLY TECHNIQUE TO OPERATE
    • TABLE 131 PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 132 NORTH AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 133 EUROPE: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 135 LATIN AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 136 MIDDLE EAST: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 137 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.4 NANOFILTRATION
    • 7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH
    • TABLE 138 PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 139 NORTH AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 140 EUROPE: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 142 LATIN AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 143 MIDDLE EAST: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 144 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.5 OTHER TECHNIQUES
    • TABLE 145 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 146 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 147 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 149 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 150 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 151 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022-2029 (USD MILLION)

8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 152 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 8.2 FINAL PRODUCT PROCESSING
    • TABLE 153 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 154 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 155 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 156 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 158 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 159 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 160 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION
      • 8.2.1.1 Continuous requirement for API filtration to drive market
    • TABLE 161 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 162 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 163 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 165 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 166 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 167 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.2 PROTEIN PURIFICATION
      • 8.2.2.1 Advancements in protein therapeutic drugs to propel growth
    • TABLE 168 PROTEIN PURIFICATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 169 NORTH AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 170 EUROPE: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 171 ASIA PACIFIC: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 172 LATIN AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 173 MIDDLE EAST: PROTEIN PURIFICATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 174 GCC COUNTRIES: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.3 VACCINE AND ANTIBODY PROCESSING
      • 8.2.3.1 Rising investments in life science R&D to drive growth
    • TABLE 175 VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 176 NORTH AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 177 EUROPE: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 178 ASIA PACIFIC: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 179 LATIN AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 180 MIDDLE EAST: VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 181 GCC COUNTRIES: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.4 FORMULATION AND FILLING SOLUTIONS
      • 8.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth
    • TABLE 182 FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 183 NORTH AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 184 EUROPE: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 185 ASIA PACIFIC: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 186 LATIN AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 187 MIDDLE EAST: FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 188 GCC COUNTRIES: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.2.5 VIRAL CLEARANCE
      • 8.2.5.1 Development of therapeutic monoclonal antibodies to drive market
    • TABLE 189 VIRAL CLEARANCE MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 190 NORTH AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 191 EUROPE: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 192 ASIA PACIFIC: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 193 LATIN AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 194 MIDDLE EAST: VIRAL CLEARANCE MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 195 GCC COUNTRIES: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3 RAW MATERIAL FILTRATION
    • TABLE 196 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 197 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 198 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 199 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 200 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 201 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 202 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 203 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.3.1 MEDIA AND BUFFER FILTRATION
      • 8.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market
    • TABLE 204 MEDIA AND BUFFER FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 205 NORTH AMERICA: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 206 EUROPE: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 208 LATIN AMERICA: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 209 MIDDLE EAST: MEDIA AND BUFFER FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 210 GCC COUNTRIES: MEDIA AND BUFFER FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.3.2 PREFILTRATION
      • 8.3.2.1 Membrane fouling issues to support market growth
    • TABLE 211 PREFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 212 NORTH AMERICA: PREFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 213 EUROPE: PREFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: PREFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 215 LATIN AMERICA: PREFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 216 MIDDLE EAST: PREFILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 217 GCC COUNTRIES: PREFILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 8.3.3 BIOBURDEN TESTING
      • 8.3.3.1 Strict quality control of biopharmaceuticals to propel growth
    • TABLE 218 BIOBURDEN TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 219 NORTH AMERICA: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 220 EUROPE: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 221 ASIA PACIFIC: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 222 LATIN AMERICA: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 223 MIDDLE EAST: BIOBURDEN TESTING MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 224 GCC COUNTRIES: BIOBURDEN TESTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.4 CELL SEPARATION
    • 8.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET
    • TABLE 225 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 226 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 227 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 228 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 229 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 230 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 231 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.5 WATER PURIFICATION
    • 8.5.1 INCREASING DEMAND FOR PURIFIED WATER FROM HOSPITALS TO DRIVE MARKET
    • TABLE 232 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 233 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 234 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 235 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 236 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 237 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 238 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.6 AIR PURIFICATION
    • 8.6.1 INCREASING ADOPTION OF GMP PRACTICES TO SUPPORT MARKET GROWTH
    • TABLE 239 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 240 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 241 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 242 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 243 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 244 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 245 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2022-2029 (USD MILLION)

9 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE

  • 9.1 INTRODUCTION
    • TABLE 246 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 9.2 STERILE FILTRATION
    • 9.2.1 GROWING DEMAND FOR BIOLOGICS DRUGS TO DRIVE DEMAND
    • TABLE 247 PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 248 NORTH AMERICA: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 249 EUROPE: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 250 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 251 LATIN AMERICA: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 252 MIDDLE EAST: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 253 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.3 NON-STERILE FILTRATION
    • 9.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROPEL MARKET
    • TABLE 254 PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 255 NORTH AMERICA: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 256 EUROPE: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 257 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 258 LATIN AMERICA: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 259 MIDDLE EAST: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 260 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE NON-STERILE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

10 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION

  • 10.1 INTRODUCTION
    • TABLE 261 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
  • 10.2 MANUFACTURING SCALE
    • 10.2.1 GROWTH IN MANUFACTURING OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET
    • TABLE 262 MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 263 NORTH AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 264 EUROPE: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 265 ASIA PACIFIC: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 266 LATIN AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 267 MIDDLE EAST: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 268 GCC COUNTRIES: MANUFACTURING-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 10.3 PILOT SCALE
    • 10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH
    • TABLE 269 PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 270 NORTH AMERICA: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 271 EUROPE: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 272 ASIA PACIFIC: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 273 LATIN AMERICA: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 274 MIDDLE EAST: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 275 GCC COUNTRIES: PILOT-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 10.4 R&D SCALE
    • 10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH
    • TABLE 276 R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 277 NORTH AMERICA: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 278 EUROPE: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 279 ASIA PACIFIC: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 280 LATIN AMERICA: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 281 MIDDLE EAST: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 282 GCC COUNTRIES: R&D-SCALE PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

11 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 283 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 31 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT
    • TABLE 284 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 285 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 286 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 287 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 288 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 289 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 290 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 291 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 292 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 293 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 294 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 Technological advancements in filtration membranes to support market growth
    • TABLE 295 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 296 US: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 297 US: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 298 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 299 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 300 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 301 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 302 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 303 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 304 US: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Growing government support for expanding manufacturing facilities to drive market
    • TABLE 305 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 306 CANADA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 307 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 308 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 309 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 310 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 311 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 312 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 313 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 314 CANADA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.2.3 NORTH AMERICA: RECESSION IMPACT
  • 11.3 EUROPE
    • TABLE 315 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 316 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 317 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 318 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 319 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 320 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 321 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 322 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 323 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 324 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 325 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Growing pharmaceutical R&D and manufacturing to drive market
    • TABLE 326 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 327 GERMANY: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 328 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 329 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 330 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 331 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 332 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 333 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 334 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 335 GERMANY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Increased R&D investments and government aid to boost market growth
    • TABLE 336 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 337 UK: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 338 UK: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 339 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 340 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 341 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 342 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 343 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 344 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 345 UK: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Increasing government investments in pharmaceutical industry to drive growth
    • TABLE 346 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 347 FRANCE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 348 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 349 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 350 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 351 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 352 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 353 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 354 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 355 FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Rising research activities in pharma R&D to boost market growth
    • TABLE 356 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 357 ITALY: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 358 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 359 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 360 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 361 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 362 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 363 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 364 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 365 ITALY: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Expansion of biomanufacturing facilities to support market growth
    • TABLE 366 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 367 SPAIN: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 368 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 369 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 370 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 371 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 372 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 373 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 374 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 375 SPAIN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 376 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 377 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 378 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 379 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 380 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 381 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 382 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 383 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 384 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 385 REST OF EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.3.7 EUROPE: RECESSION IMPACT
  • 11.4 ASIA PACIFIC
    • FIGURE 32 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET SNAPSHOT
    • TABLE 386 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 387 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 388 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 389 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 390 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 391 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 392 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 393 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 394 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 395 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 396 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.4.1 CHINA
      • 11.4.1.1 China to dominate Asia Pacific market during forecast period
    • TABLE 397 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 398 CHINA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 399 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 400 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 401 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 402 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 403 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 404 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 405 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 406 CHINA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Stringent regulatory guidelines to increase demand for advanced filtration products
    • TABLE 407 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 408 JAPAN: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 409 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 410 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 411 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 412 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 413 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 414 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 415 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 416 JAPAN: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Government initiatives to favor market growth
    • TABLE 417 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 418 INDIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 419 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 420 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 421 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 422 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 423 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 424 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 425 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 426 INDIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.4.4 SOUTH KOREA
      • 11.4.4.1 Increased export of drugs to support market growth
    • TABLE 427 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 428 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 429 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 430 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 431 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 432 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 433 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 434 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 435 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 436 SOUTH KOREA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Increasing demand for innovative filtration solutions to propel market
    • TABLE 437 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 438 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 439 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 440 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 441 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 442 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 443 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 444 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 445 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 446 AUSTRALIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.4.6 REST OF ASIA PACIFIC
    • TABLE 447 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 448 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 449 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 450 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 451 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 452 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 453 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 454 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 455 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 456 REST OF ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.4.7 ASIA PACIFIC: RECESSION IMPACT
  • 11.5 LATIN AMERICA
    • TABLE 457 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 458 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 459 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 460 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 461 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 462 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 463 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 464 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 465 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 466 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 467 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.5.1 BRAZIL
      • 11.5.1.1 Growth of vaccine manufacturing to drive market
    • TABLE 468 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 469 BRAZIL: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 470 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 471 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 472 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 473 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 474 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 475 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 476 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 477 BRAZIL: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.5.2 MEXICO
      • 11.5.2.1 Rising demand for chronic disease treatment to support market growth
    • TABLE 478 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 479 MEXICO: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 480 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 481 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 482 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 483 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 484 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 485 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 486 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 487 MEXICO: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.5.3 REST OF LATIN AMERICA
    • TABLE 488 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 489 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 490 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 491 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 492 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 493 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 494 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 495 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 496 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 497 REST OF LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.5.4 LATIN AMERICA: RECESSION IMPACT
  • 11.6 MIDDLE EAST
    • TABLE 498 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 499 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 500 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 501 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 502 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 503 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 504 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 505 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 506 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 507 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 508 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.6.1 GCC COUNTRIES
    • TABLE 509 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 510 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 511 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 512 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 513 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 514 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 515 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 516 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 517 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 518 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 519 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
      • 11.6.1.1 Saudi Arabia
        • 11.6.1.1.1 Growing healthcare expenditure to boost market growth
    • TABLE 520 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 521 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 522 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 523 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 524 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 525 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 526 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 527 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 528 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 529 SAUDI ARABIA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
      • 11.6.1.2 UAE
        • 11.6.1.2.1 Rapidly growing pharmaceutical industry to aid market growth
    • TABLE 530 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 531 UAE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 532 UAE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 533 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 534 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 535 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 536 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 537 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 538 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 539 UAE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
      • 11.6.1.3 Rest of GCC countries
    • TABLE 540 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 541 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 542 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 543 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 544 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 545 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 546 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 547 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 548 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 549 REST OF GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.6.2 REST OF MIDDLE EAST
    • TABLE 550 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 551 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 552 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 553 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 554 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 555 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 556 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 557 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 558 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 559 REST OF MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.6.3 MIDDLE EAST: RECESSION IMPACT
  • 11.7 AFRICA
    • 11.7.1 GROWING MARKET FOR PHARMACEUTICALS AND INCREASING DEMAND FOR DRUGS TO PROPEL MARKET
    • TABLE 560 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 561 AFRICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 562 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 563 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 564 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
    • TABLE 565 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 566 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 567 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 568 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 569 AFRICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2022-2029 (USD MILLION)
    • 11.7.2 AFRICA: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 570 STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2022-2024
  • 12.3 REVENUE SHARE ANALYSIS
    • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023 (USD MILLION)
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
    • TABLE 571 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DEGREE OF COMPETITION
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 35 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 12.6 COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • 12.6.1 COMPANY FOOTPRINT
    • FIGURE 36 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY FOOTPRINT
    • 12.6.2 PRODUCT FOOTPRINT
    • TABLE 572 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PRODUCT FOOTPRINT
    • 12.6.3 SCALE OF OPERATION FOOTPRINT
    • TABLE 573 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: SCALE OF OPERATION FOOTPRINT
    • 12.6.4 REGIONAL FOOTPRINT
    • TABLE 574 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: REGIONAL FOOTPRINT
  • 12.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    • 12.7.1 PROGRESSIVE COMPANIES
    • 12.7.2 STARTING BLOCKS
    • 12.7.3 RESPONSIVE COMPANIES
    • 12.7.4 DYNAMIC COMPANIES
    • FIGURE 37 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • 12.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
    • TABLE 575 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
    • TABLE 576 PHARMACEUTICAL MEMBRANE FILTRATION: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 12.9 VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL MEMBRANE FILTRATION VENDORS
    • FIGURE 38 EV/EBITDA OF KEY VENDORS
    • FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 12.10 BRAND/PRODUCT COMPARATIVE ANALYSIS
    • 12.10.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
    • FIGURE 40 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
  • 12.11 COMPETITIVE SCENARIO
    • 12.11.1 PRODUCT LAUNCHES
    • TABLE 577 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2024
    • 12.11.2 DEALS
    • TABLE 578 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DEALS, JANUARY 2021-JANUARY 2024
    • 12.11.3 EXPANSIONS
    • TABLE 579 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2024

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 13.1.1 MERCK KGAA
    • TABLE 580 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • TABLE 581 MERCK KGAA: PRODUCTS OFFERED
    • TABLE 582 MERCK KGAA: DEALS
    • TABLE 583 MERCK KGAA: OTHER DEVELOPMENTS
    • 13.1.2 DANAHER CORPORATION
    • TABLE 584 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 585 DANAHER CORPORATION: PRODUCTS OFFERED
    • TABLE 586 DANAHER CORPORATION: DEALS
    • TABLE 587 DANAHER CORPORATION: EXPANSIONS
    • 13.1.3 SARTORIUS AG
    • TABLE 588 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 43 SARTORIUS AG: COMPANY SNAPSHOT (2022)
    • TABLE 589 SARTORIUS AG: PRODUCTS OFFERED
    • TABLE 590 SARTORIUS AG: PRODUCT LAUNCHES
    • TABLE 591 SARTORIUS AG: DEALS
    • TABLE 592 SARTORIUS AG: EXPANSIONS
    • 13.1.4 THERMO FISHER SCIENTIFIC INC.
    • TABLE 593 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • TABLE 594 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
    • TABLE 595 THERMO FISHER SCIENTIFIC INC.: DEALS
    • TABLE 596 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
    • 13.1.5 3M COMPANY
    • TABLE 597 3M COMPANY: BUSINESS OVERVIEW
    • FIGURE 45 3M COMPANY: COMPANY SNAPSHOT (2022)
    • TABLE 598 3M COMPANY: PRODUCTS OFFERED
    • TABLE 599 3M COMPANY: EXPANSIONS
    • 13.1.6 PARKER HANNIFIN CORPORATION
    • TABLE 600 PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 46 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 601 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED
    • TABLE 602 PARKER HANNIFIN CORPORATION: PRODUCT LAUNCHES
    • TABLE 603 PARKER HANNIFIN CORPORATION: DEALS
    • TABLE 604 PARKER HANNIFIN CORPORATION: EXPANSIONS
    • 13.1.7 REPLIGEN CORPORATION
    • TABLE 605 REPLIGEN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 47 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 606 REPLIGEN CORPORATION: PRODUCTS OFFERED
    • TABLE 607 REPLIGEN CORPORATION: PRODUCT LAUNCHES
    • TABLE 608 REPLIGEN CORPORATION: DEALS
    • TABLE 609 REPLIGEN CORPORATION: EXPANSIONS
    • 13.1.8 ASAHI KASEI CORPORATION
    • TABLE 610 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
    • FIGURE 48 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 611 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
    • TABLE 612 ASAHI KASEI CORPORATION: EXPANSIONS
    • 13.1.9 EATON CORPORATION PLC
    • TABLE 613 EATON CORPORATION PLC: BUSINESS OVERVIEW
    • FIGURE 49 EATON CORPORATION PLC: COMPANY SNAPSHOT (2022)
    • TABLE 614 EATON CORPORATION PLC: PRODUCTS OFFERED
    • TABLE 615 EATON CORPORATION PLC: PRODUCT LAUNCHES
    • 13.1.10 GEA GROUP
    • TABLE 616 GEA GROUP: BUSINESS OVERVIEW
    • FIGURE 50 GEA GROUP: COMPANY SNAPSHOT (2022)
    • TABLE 617 GEA GROUP: PRODUCTS OFFERED
    • TABLE 618 GEA GROUP: PRODUCT LAUNCHES
    • 13.1.11 CORNING INCORPORATED
    • TABLE 619 CORNING INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 51 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
    • TABLE 620 CORNING INCORPORATED: PRODUCTS OFFERED
    • 13.1.12 ALFA LAVAL CORPORATE AB
    • TABLE 621 ALFA LAVAL CORPORATE AB: BUSINESS OVERVIEW
    • FIGURE 52 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2022)
    • TABLE 622 ALFA LAVAL CORPORATE AB: PRODUCTS OFFERED
    • 13.1.13 DONALDSON COMPANY, INC.
    • TABLE 623 DONALDSON COMPANY, INC.: BUSINESS OVERVIEW
    • FIGURE 53 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2023)
    • TABLE 624 DONALDSON COMPANY, INC.: PRODUCTS OFFERED
    • TABLE 625 DONALDSON COMPANY, INC.: PRODUCT LAUNCHES
    • TABLE 626 DONALDSON COMPANY, INC.: DEALS
    • TABLE 627 DONALDSON COMPANY, INC.: EXPANSIONS
    • 13.1.14 SAINT-GOBAIN
    • TABLE 628 SAINT-GOBAIN: BUSINESS OVERVIEW
    • FIGURE 54 SAINT-GOBAIN: COMPANY SNAPSHOT (2022)
    • TABLE 629 SAINT-GOBAIN: PRODUCTS OFFERED
    • 13.1.15 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG
    • TABLE 630 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: BUSINESS OVERVIEW
    • FIGURE 55 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: COMPANY SNAPSHOT (2022)
    • TABLE 631 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG: PRODUCTS OFFERED
    • 13.1.16 MEISSNER FILTRATION PRODUCTS, INC.
    • TABLE 632 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
    • TABLE 633 MEISSNER FILTRATION PRODUCTS, INC.: PRODUCTS OFFERED
    • TABLE 634 MEISSNER FILTRATION PRODUCTS, INC.: EXPANSIONS
    • 13.1.17 COLE-PARMER INSTRUMENT COMPANY, LLC
    • TABLE 635 COLE-PARMER INSTRUMENT COMPANY, LLC.: BUSINESS OVERVIEW
    • TABLE 636 COLE-PARMER INSTRUMENT COMPANY, LLC.: PRODUCTS OFFERED
    • 13.1.18 APPLEXION
    • TABLE 637 APPLEXION: BUSINESS OVERVIEW
    • TABLE 638 APPLEXION: PRODUCTS OFFERED
    • 13.1.19 CANTEL MEDICAL CORP.
    • TABLE 639 CANTEL MEDICAL CORP.: BUSINESS OVERVIEW
    • TABLE 640 CANTEL MEDICAL CORP.: PRODUCTS OFFERED
    • 13.1.20 W. L. GORE & ASSOCIATES, INC.
    • TABLE 641 W. L. GORE & ASSOCIATES, INC.: BUSINESS OVERVIEW
    • TABLE 642 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 13.2 OTHER PLAYERS
    • 13.2.1 MEMBRANE SOLUTIONS
    • TABLE 643 MEMBRANE SOLUTIONS: BUSINESS OVERVIEW
    • 13.2.2 AMAZON FILTERS LTD.
    • TABLE 644 AMAZON FILTERS LTD.: BUSINESS OVERVIEW
    • 13.2.3 TOYO ROSHI KAISHA, LTD.
    • TABLE 645 TOYO ROSHI KAISHA, LTD.: BUSINESS OVERVIEW
    • 13.2.4 PORVAIR PLC
    • TABLE 646 PORVAIR PLC: BUSINESS OVERVIEW
    • 13.2.5 STERLITECH CORPORATION
    • TABLE 647 STERLITECH CORPORATION: BUSINESS OVERVIEW
    • 13.2.6 SYNDER FILTRATION, INC.
    • TABLE 648 SYNDER FILTRATION, INC.: BUSINESS OVERVIEW
    • 13.2.7 GRAVER TECHNOLOGIES, LLC
    • TABLE 649 GRAVER TECHNOLOGIES, LLC: BUSINESS OVERVIEW
    • 13.2.8 KOCH MEMBRANE SYSTEMS, INC.
    • TABLE 650 KOCH MEMBRANE SYSTEMS, INC.: BUSINESS OVERVIEW
    • 13.2.9 NUPORE FILTRATION SYSTEMS
    • TABLE 651 NUPORE FILTRATION SYSTEMS: BUSINESS OVERVIEW
    • 13.2.10 COBETTER FILTRATION EQUIPMENT CO., LTD.
    • TABLE 652 COBETTER FILTRATION EQUIPMENT CO., LTD.: BUSINESS OVERVIEW

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS